trial · primary record
Venetoclax
AML
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 788 |
| Primary completion | 2031-04-01 |
| Primary endpoint | Disease-Free Survival |
| Registry ID | NCT07539818 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:18.747Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07539818
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.